Credit Suisse’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Credit Suisse’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-24,860	Closed	-$967K	–	4409
2017 Q3	$967K	Sell	24,860 -15,641	-39%	-$575K	﹤0.01%	3127
2017 Q2	$1.21M	Buy	40,501 +29,870	+281%	+$774K	﹤0.01%	2578
2017 Q1	$282K	Buy	+10,631	New	+$263K	﹤0.01%	3535
2016 Q1	–	Sell	-10,662	Closed	-$182K	–	4562
2015 Q4	$182K	Buy	+10,662	New	+$208K	﹤0.01%	3927

Other funds holding NDRM

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Credit Suisse's NDRM Position: Q4 2017 in Review

Credit Suisse sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 24,860 shares — an estimated $967K sold.

Credit Suisse first reported a position in NDRM in Q4 2015 and held it in 4 quarters. The position peaked at $1.21M in Q2 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

Credit Suisse reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
Credit Suisse sold 24,860 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $967K.
Credit Suisse first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 4 quarters.
Credit Suisse's NeuroDerm Ltd. Ordinary Shares position peaked at $1.21M in Q2 2017.
5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.